SOURCE-LINKED INTELLIGENCE

DEVELOPMENT OF THERAPEUTIC CANDIDATES FOR STIMULANT USE DISORDER USING AI-DRIVEN PLATFORM FOR FOCUSED DRUG DISCOVERY AND ACCELERATED DEVELOPMENT - PROJECT SUMMARY STIMULANT USE DISORDER (STUD) IS EMERGING AS A SERIOUS GL

USAspending · observation · Publication date unknown

DEVELOPMENT OF THERAPEUTIC CANDIDATES FOR STIMULANT USE DISORDER USING AI-DRIVEN PLATFORM FOR FOCUSED DRUG DISCOVERY AND ACCELERATED DEVELOPMENT - PROJECT SUMMARY STIMULANT USE DISORDER (STUD) IS EMERGING AS A SERIOUS GLOBAL THREAT TO HEALTH, WITH AN EXPONENTIAL RISE IN PREVALENCE AND OVERDOSE DEATHS. IN 2022, 60 MILLION PEOPLE REPORTED PAST YEAR USE OF STIMULANTS, WITH 35 MILLION PEOPLE MEETING THE CRITERIA FOR A STUD CURRENTLY, THERE ARE NO FDA- APPROVED MEDICATIONS FOR TREATING STUD, LEAVING ONLY COSTLY AND OFTEN INEFFECTIVE ABSTINENCE SUPPORT AND BEHAVIORAL THERAPIES, AS EVIDENCED BY RELAP

Read original source ↗ Open in workspace

recordType

award

region

US

value

1324520

unit

USD